Body fluid biomarkers in multiple sclerosis
- 1 January 2014
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 13 (1), 113-126
- https://doi.org/10.1016/s1474-4422(13)70233-3
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Personalized medicine using DNA biomarkers: a reviewHuman Genetics, 2012
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Aggregation of multiple sclerosis genetic risk variants in multiple and single case familiesAnnals of Neurology, 2010
- The role of osteopontin in inflammatory processesJournal of Cell Communication and Signaling, 2009
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility lociNature Genetics, 2009
- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple SclerosisArchives of Neurology, 2009
- HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple SclerosisAmerican Journal of Human Genetics, 2008
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisPublished by American Medical Association (AMA) ,2006
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006